TY - JOUR T1 - Years of Life Lost in the United States During the COVID-19 Pandemic, March 2020 to October 2021 JF - medRxiv DO - 10.1101/2022.07.22.22277899 SP - 2022.07.22.22277899 AU - Mark É. Czeisler AU - Charles A. Czeisler Y1 - 2022/01/01 UR - http://medrxiv.org/content/early/2022/07/22/2022.07.22.22277899.abstract N2 - Background Given a downward age shift in COVID-19-involved deaths observed during the COVID-19 pandemic, we sought to estimate years of life lost (YLL) associated with leading causes of US death during the first 20 months of the pandemic.Findings Despite 4796 fewer COVID-19 deaths in Jan-Oct 2021 than in Mar-Dec 2020, the number of YLL due to COVID-19 increased by 1,159,761, from 4,474,186 to 5,633,947 (a 25.9% increase). YLL per COVID-19 death increased from 12.8 in 2020 to 16.3 in 2021, a 27.7% increase. YLL per death did not change by more than 2.3% for any other cause.Interpretation Increased YLL per COVID-19 death in 2021 result from younger-age COVID-19 mortality, contributing to a marked increase in YLL from this preventable cause of death at a later stage of the pandemic despite advancements in vaccines in treatments.Competing Interest StatementM.É.C. received consultant payments from Vanda Pharmaceuticals and institutional grants paid to Monash University from the CDC and CDC Foundation, with funding provided by BNY Mellon, and from WHOOP, Inc., as well as an institutional gift to Monash University from Hopelab, Inc. C.A.C. reports grants/contracts to BWH from Dayzz Live Well, Delta Airlines, Jazz Pharma, Puget Sound Pilots, Regeneron Pharmaceuticals/Sanofi; is/was paid consultant/speaker for Institute of Digital Media and Child Development, Klarman Family Foundation, National Council for Mental Wellbeing, National Sleep Foundation, Physician's Seal, SRS Foundation, Tencent, Teva Pharma Australia, With Deep, and Vanda Pharmaceuticals; holds an equity interest in With Deep and Vanda Pharmaceuticals; received travel support from Aspen Brain Institute, Bloomage International, Dr. Stanley Ho Medical Development Foundation, German National Academy of Sciences, National Safety Council, National Sleep Foundation, Stanford Medical School, and Vanda; receives research/education gifts through BWH from Arbor Pharmaceuticals, Avadel Pharmaceuticals, Bryte, Alexandra Drane, DR Capital Ltd, Eisai, Harmony Biosciences, Jazz Pharmaceuticals, Johnson and Johnson, Mary Ann & Stanley Snider via Combined Jewish Philanthropies, NeuroCare, Inc., Optum, Philips Respironics, Regeneron, Regional Home Care, ResMed, San Francisco Bar Pilots, Sanofi, Schneider, Simmons, Sleep Cycle. Sleep Number, Sysco, Teva Pharmaceuticals, Vanda; is/was an expert witness in legal cases, including those involving Advanced Power Technologies, Aegis Chemical Solutions, Amtrak; Casper Sleep Inc., C and J Energy Services, Catapult Energy Services Group, Covenant Testing Technologies, Dallas Police Association, Enterprise Rent-A-Car, Espinal Trucking/Eagle Transport Group/Steel Warehouse Inc., FedEx, Greyhound, PAR Electrical Contractors, Product and Logistics Services LLC/Schlumberger Technology, Puckett EMS, Puget Sound Pilots, Union Pacific Railroad, UPS, and Vanda; royalties from Philips Respironics for the Actiwatch-2 and Actiwatch Spectrum devices. C.A.C.'s interests were reviewed and are managed by the BWH and MGB in accordance with their conflict-of-interest policies. No other disclosures were reported.Funding StatementNo direct funding supported this analysis. C.A.C. is the incumbent of an endowed professorship provided to Harvard University by Cephalon, Inc.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study used openly available human data that were originally located at CDC WONDER and the National Vital Statistics System.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced are available online at CDC Wonder and the National Vital Statistics System. https://wonder.cdc.gov/ https://www.cdc.gov/nchs/nvss/life-expectancy.htm ER -